Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2

Journal of Clinical Investigation

Volumn 105, Issue 2, 2000, Pages 199-205

  Kido, Yoshiaki ^a,e   Burks, Deborah J ^b   Withers, Dominic ^b   Bruning, Jens C ^b   Kahn, C Ronald ^b   White, Morris F ^b,c   Accili, Domenico ^a,d,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d Berrie Research Pavilion   (United States)

^e The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENOTYPE; HETEROZYGOSITY; INSULIN RESISTANCE; LIVER; MOUSE; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL HYPERPLASIA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0033966768     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7917     Document Type: Article

References (39)

1. Kahn, C.R. 1996. New concepts in the pathogenesis of diabetes mellitus. Adv. Intern. Med. 41:285-321.
2. Taylor, S.I. 1999. Deconstructing type 2 diabetes. Cell. 97:9-12.
3. Polonsky, K.S., Sturis, J., and Bell, G.I. 1996. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334:777-783.
4. Lauro, D., et al. 1998. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat. Genet. 20:294-298.
5. Bruning, J.C., et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell. 2:559-569.
6. Kulkarni, R.N., et al. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
7. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
8. White, M.F. 1998. The IRS-signalling system: a network of docking proteins that mediate insulin and interleukin signalling. Mol. Cell. Biochem. 182:3-11.
9. Yamauchi, Y., et al. 1996. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate I-deficient mice. Mol. Cell. Biol. 16:3074-3084.
10. Accili, D., et al. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106-109.
11. Liu, J.P., Baker, J., Perkins, A.S., Robertson, E.J., and Efstratiadis, A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
12. Tamemoto, H., et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:182-186.
13. Araki, E., et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190.
14. Lavan, B., et al. 1998. Tyrosine phosphorylation in insulin action. Proceedings of the 80th Annual Meeting of the Endocrine Society, New Orleans, LA. 36.
15. Liu, S.C.H., Wang, Q., Lienhard, G.E., and Keller, S.R. 1999. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J. Biol. Chem. 274:18093-18099.
16. Louvi, A., Accili, D., and Efstratiadis, A. 1997. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev. Biol. 189:33-48.
17. Di Cola, G., Cool, M.H., and Accili, D. 1997. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J. Clin. Invest. 99:2538-2544.
18. Kulkarni, R., Winnay, J., Bruning, J., and Hanahan, D. 1998. Altered insulin secretion patterns in IRS-1 deficient pancreatic beta-cells. Diabetes. 47(Suppl. 1):A57 (Abstr.).
19. Potzio, O., et al. 1999. The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J. Clin. Invest. 104:357-364.
20. Withers, D.J., et al. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23:32-40.
21. Bruning, J.C., et al. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 88:561-572.
22. Ghosh, S., and Schork, N.J. 1996. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes. 45:1-14.
23. Kahn, C.R., Vicent, D., and Doria, A. 1996. Genetics of non-insulin-dependent(type-II) diabetes mellitus. Annu. Rev. Med. 47:509-531.
24. Ghosh, S., and Collins, F.S. 1996. The geneticist's approach to complex disease. Annu. Rev. Med. 47:333-353.
25. Almind, K., et al. 1993. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 342:828-832.
26. Imai, Y., et al. 1994. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 79:1655-1658.
27. Almind, K., Inoue, G., Pedersen, O., and Kahn, C.R. 1996. A common amino acid polymorphism in insulin receptor substrates-1 causes impaired insulin signaling. J. Clin. Invest. 97:2569-2575.
28. Imai, Y., Philippe, N., Sesti, G., Accili, D., and Taylor, S.I. 1997. Expression of variant forms of insulin receptor substrate-1 identified in patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82:4201-4207.
29. Kido, Y., and Accili, D. 1998. The susceptibility to diabetes in mice carrying a null allele of the insulin receptor gene is genetically determined. Diabetes. 47(Suppl. 1):A178.
30. Cherrington, A.D. 1999. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes. 48:1198-1214.
31. Michael, M., et al. 1999. Liver-specific insulin receptor knockout mice are severely insulin resistant. Diabetes. 48(Suppl. 1):A10. (Abstr.)
32. Sun, X.J., et al. 1991. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:73-77.
33. Sun, X.J., et al. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:173-177.
34. Lavan, B.E, Lane, W.S., and Lienhard, G.E. 1997. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:13439-11443.
35. Lavan, B.E., et al. 1997. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:21403-21407.
36. Holgado-Madruga, M., Emler, D.R., Moscatello, D.K., Godwin, A.K., and Wong, A.J. 1996. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature. 379:560-564.
37. Rother, K.I., et al. 1998. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol. Chem. 273:17491-17497.
38. Bruning, J.C., Winnay, J., Cheatham, B., and Kahn, C.R. 1997. Differential signaling by insulin receptor substrate 1 (IRS-1) and ERS-2 in IRS-1-deficient cells. Mol. Cell. Biol. 17:1513-1521.
39. Lander, E.S., and Schork, N.J. 1994. Genetic dissection of complex traits. Science. 265:2037-2048.